Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Children's PediaCare Multi-Symptom Cold is an over-the-counter (OTC) combination medication designed for the temporary relief of symptoms associated with the common cold, flu, and upper respiratory allergies in children aged 4 to 11. The formulation typically includes four active ingredients: acetaminophen (a pain reliever and fever reducer), chlorpheniramine maleate (an antihistamine), dextromethorphan hydrobromide (a cough suppressant), and phenylephrine hydrochloride (a nasal decongestant). Acetaminophen works by inhibiting prostaglandin synthesis in the central nervous system; chlorpheniramine blocks H1 histamine receptors; dextromethorphan acts on the cough center in the medulla to elevate the cough threshold; and phenylephrine is an alpha-1 adrenergic agonist that causes vasoconstriction in the nasal mucosa. While the brand name has been reported as discontinued in the U.S. by some sources, various formulations under the PediaCare umbrella have historically been manufactured and distributed by companies such as Strides Pharma and Fareva Richmond.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Children's PediaCare Multi-Symptom Cold.